The fluorescent labeling compound—dubbed "Sialyl Lewis Yellow"—was developed by an international team led from the Pohang University of Science and Technology in South Korea. It works by binding to ...

Zetagen Therapeutics Announces Peer-reviewed Publication of In-Vivo Dose Optimization Findings for ZetaMast™ (Zeta-MBC-005) for Triple Negative Breast Cancer Liver Metastases (Patients with ...

Liver metastases occur when cancer tumors spread to the liver from another part of the body. Learn more about liver metastases here.

Liver regeneration is an important model of regenerative growth of tissues with an unclear mechanism. Monitoring the hemodynamic changes during liver regeneration may facilitate the understanding of ...

Ex vivo liver resection and auto-transplantation for cholangiocarcinoma.. If you have the appropriate software installed, you can download article citation data to the citation manager of your choice.

In vivo CRISPR Editing Results in Functional Upregulation of a Liver Target Protein and Meaningful Reduction of Disease-Associated Biomarker in Mice CAMBRIDGE, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- ...

In vivo CRISPR Editing Results in Functional Upregulation of a Liver Target Protein and Meaningful Reduction of Disease-Associated Biomarker in Mice CAMBRIDGE, Mass., May 13, 2025 (GLOBE NEWSWIRE ...

CRISPR Tx reported reductions in triglycerides and LDL cholesterol of more than 80% after a single dose of its in vivo liver editing prospect CTX310.

Additionally, sampling different liver lobes is recommended, as there may be variation between different lobes. Finally, samples should also be submitted for aerobic and anaerobic culture and copper ...

Biomarker staging of liver fibrosis in hepatitis C was cost effective, but so was initiating treatment without testing.

(Patients with disseminated metastatic disease from breast cancer are likely to have liver involvement in >50% of cases at some point during disease progression.) Zetagen identifies two ...

A phase 3 trial of GSK’s linerixibat in a liver disease has hit its primary endpoint, keeping the drugmaker on track to launch the first treatment for the relentless itching experienced by some ...